本页面由Tiger Trade Technology Pte. Ltd.提供服务

Aura Biosciences, Inc.

6.29
-0.2550-3.90%
成交量:101.94万
成交额:648.05万
市值:6.50亿
市盈率:-3.55
高:6.56
开:6.53
低:6.18
收:6.54
52周最高:9.54
52周最低:4.73
股本:1.03亿
流通股本:7,464.31万
量比:1.23
换手率:1.37%
股息:- -
股息率:- -
每股收益(TTM):-1.7726
每股收益(LYR):-1.7599
净资产收益率:-53.49%
总资产收益率:-31.24%
市净率:2.06
市盈率(LYR):-3.57

数据加载中...

2026/10/02

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/09/01

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/08/14

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/14

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/08/12

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/11

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/11

重要事件披露

Form 8-K - Current report
2026/08/06

重要事件披露

Form 8-K - Current report
2026/07/28

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/07/08

重要事件披露

Form 8-K - Current report
2026/06/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/12

重要事件披露

Form 8-K - Current report
2026/05/20

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/05/12

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/05/12

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/12

重要事件披露

Form 8-K - Current report
2026/05/05

重要事件披露

Form 8-K - Current report
2026/05/05

重要事件披露

Form 8-K - Current report
2026/05/04

重要事件披露

Form 8-K - Current report
2026/04/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities